FDA NDC Directory · JSON-LD · Markdown

ERLOTINIB

NDC 31722-265 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA209267
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsERLOTINIB HYDROCHLORIDE (150 mg/1)
Marketing started20240524
Package count1

External sources

Source: openFDA. Public-domain (CC0).